Table 1 The input values for clinical options for breast cancer detection derived from a literature search
Proposed Diagnostic Tests/Assays | SN | SP | Cost($) | Reference | PMID |
|---|---|---|---|---|---|
Magnetic Resonance Imaging (MRI) | 0.96 | 0.75 | 100.00 | Imbriaco et al. 2001 [11] | |
Electrical Impedance Scanning | 0.38 | 0.95 | 100.00 | Stojadinovic et al., 2006 [12] | |
electronic resonance spectroscopy of albumin configuration | 0.85 | 0.91 | 100.00 | Seidel et al., 2005 [13] | |
SCM Test | 0.81 | 0.85 | 100.00 | Klein et al., 2002 [14] | |
Serum TSGF | 0.6386 | 0.9089 | 100.00 | Liang et al., 2002 [15] | |
mammaglobin (cutpoint 8.8) | 0.688 | 0.888 | 100.00 | Bernstein et al., 2005 [16] | |
SELDI (serum), CART, two surfaces | 0.9 | 0.93 | 100.00 | Vlahou et al., 2003 [17] | |
scintimammography on px w/suspicious breast mass | 0.9 | 0.938 | 100.00 | Polan et al., 2001 [18] | |
NAS bFGF, race, menopausal status + PSA | 0.909 | 0.833 | 100.00 | Hsiung et al., 2002 [19] | |
cytology alone, breast ductal lavage cells | 0.67 | 0.93 | 100.00 | Zhang et al., 2006 [20] | |
G-actin biomarker, breast ductal lavage cells | 0.9 | 1 | 100.00 | Zhang et al., 2006 [20] | |
DNA5cER biomarker, breast ductal lavage cells | 1 | 0.93 | 100.00 | Zhang et al., 2006 [20] |